loading

Recent events

GLuna Shrimp owner Gabriel Luna

AdvertisementX
AdvertisementX

Aquaculture

UK’s Benchmark opens £17m vaccine antigen facility

The state-of-the-art biotechnology building processed its first commercial-scale batch of antigen for use in new aquaculture vaccines and now awaits an EU rubber stamp

By Undercurrent News | Oct. 17, 2017 08:51 BST
Related

Benchmark renews distribution agreement for Great Salt Lake artemia

Benchmark renews distribution agreement for Great Salt Lake artemia

Benchmark starts trials of disease-resistant shrimp in Southeast Asia

Shrimp

UK’s Benchmark still in red but organic growth strong

Benchmark, SalMar to form salmon breeding JV

Benchmark, SalMar to form salmon breeding JV

Sitagri index: Norway salmon prices climb again

H&G pollock market poised as Chinese want lower prices, Russians push for more

Russian pollock catching. Credit: Russian fishery agency
AdvertisementX

The UK's Benchmark Holdings has commenced operations at its new £17 million vaccine antigen production facility in Braintree, UK, according to a press release.  [...]

Want to keep reading?

Sign up for a trial to have access to our articles!

Faroese gov’t restructures salmon farming taxation

Northern Norway whitefish factory put up for sale

Norwegian fresh salmon export value kicks off 2025 up 12%

Spanish wholesale prices for European bass, bream start 2025 mostly flat

Philosofish seabass seabream
AdvertisementX

Stay on the pulse

Get recommendations, data, editor’s picks, and the latest news from around the seafood world straight to your inbox.

Select your interests

Please select at least one newsletter d indicates our daily newsletters | 2w indicates twice-weekly | All others sent weekly All briefings are sent weekly, unless otherwise indicated
Region
Breaking news
Jobs
Species
Topic

Fill in your details

Please select at least one newsletter!
  • (eg new industry reports, prices data)
  • (eg subscription or report early birds)
  • (eg advertising, trade shows news)
How we handle your data We never share, sell or distribute our subscribers’ data. You may at any time unsubsribe from our newsletters, and request that we erase all information stored about you. Please check our Privacy policy for more details.

We use MailChimp and HubSpot as our email campaign platforms. By subscribing, you agree that the information you provide will be transferred to MailChimp and HubSpot for processing in accordance with their privacy policies (MailChimp privacy policy, HubSpot privacy policy) and terms (MailChimp terms, HubSpot terms).

Thank you. Please check your inbox to confirm your selection and start receiving newsletters.

Cookies on Undercurrent News

We use cookies for performance, security and analytics. To stop seeing this banner click Accept, or select Manage cookies to set your preferences and privacy settings.